<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1272034</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2023.1272034</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Copper-catalyzed reaction of aziridine for the synthesis of substituted imidazolidine and imidazolidinone</article-title>
<alt-title alt-title-type="left-running-head">Hashimoto et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1272034">10.3389/fchem.2023.1272034</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>Kota</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Higuchi</surname>
<given-names>Daiki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsubara</surname>
<given-names>Satoshi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Murakami</surname>
<given-names>Kei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2235926/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Chemistry</institution>, <institution>School of Science</institution>, <institution>Kwansei Gakuin University</institution>, <addr-line>Sanda</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>JST-PRESTO</institution>, <addr-line>Chiyoda</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2109782/overview">Takashi Ohshima</ext-link>, Kyushu University, Japan</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2349067/overview">Tao Shi</ext-link>, The Scripps Research Institute, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1923307/overview">Mar&#xed;a De Gracia Retamosa</ext-link>, University of Alicante, Spain</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Kei Murakami, <email>kei.murakami@kwansei.ac.jp</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1272034</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>08</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Hashimoto, Higuchi, Matsubara and Murakami.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Hashimoto, Higuchi, Matsubara and Murakami</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Herein we report a copper-catalyzed synthesis of imidazolidine by employing the reaction of aziridine with imine. The reaction smoothly provided a diverse range of 2-substituted imidazolidines with high compatibility with various functional groups. Moreover, during our investigation, we discovered that isocyanate also reacted with aziridine to yield substituted imidazolidinones efficiently. The versatility of these reactions was further demonstrated by their application in the synthesis of hybrid molecules derived from two pharmaceutical compounds. This approach opens new possibilities for the discovery of novel classes of bioactive molecules.</p>
</abstract>
<kwd-group>
<kwd>copper catalyst</kwd>
<kwd>aziridine</kwd>
<kwd>imine</kwd>
<kwd>isocyanate</kwd>
<kwd>imidazolidine</kwd>
<kwd>imidazolidinone</kwd>
<kwd>cyclization</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Organic Chemistry</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>The construction of saturated nitrogen-containing heterocycles is of utmost importance as they are prevalent structures in a wide range of natural products and pharmaceuticals (<xref ref-type="bibr" rid="B14">Smith et al., 1999</xref>; <xref ref-type="bibr" rid="B1">Antonopoulos et al., 2008</xref>). Among such saturated azaheterocycles, the synthesis of substituted imidazolidines has received comparatively less attention than other mono-azaheterocycles, such as pyrrolidines. However, given that imidazolidine scaffolds have been identified in numerous bioactive molecules, the development of new synthetic methodologies for accessing these scaffolds is highly important (<xref ref-type="fig" rid="F1">Figure 1A</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Background of this research.</p>
</caption>
<graphic xlink:href="fchem-11-1272034-g001.tif"/>
</fig>
<p>To access imidazolidine derivatives, aziridines have been widely employed as the starting materials (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Aziridines can be categorized into three types based on their reactivity: i) activated dipolar aziridines (<xref ref-type="bibr" rid="B17">Wu and Zhang, 2012</xref>; <xref ref-type="bibr" rid="B13">Shi et al., 2021</xref>), ii) activated vinyl aziridines (<xref ref-type="bibr" rid="B5">Lin et al., 2018</xref>; <xref ref-type="bibr" rid="B15">Spielmann et al., 2018</xref>), and iii) other substituted aziridines (<xref ref-type="bibr" rid="B6">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="B12">Sengoden et al., 2017</xref>; <xref ref-type="bibr" rid="B4">Li et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Tu et al., 2019</xref>; <xref ref-type="bibr" rid="B11">Pradhan et al., 2020</xref>). For type i), Shi et al. reported in 2021 the reaction of donor-accepter-type aziridines with 1,3,5-triazinanes through a [3 &#x2b; 2] cycloaddition (<xref ref-type="bibr" rid="B13">Shi et al., 2021</xref>). This reaction demonstrated that aziridines can serve as efficient precursors for the synthesis of multi-substituted imidazolidines. Regarding type ii), Spielmann et al. reported the palladium-catalyzed [3 &#x2b; 2] cycloaddition reaction of vinylaziridines with cyclic imines (<xref ref-type="bibr" rid="B15">Spielmann et al., 2018</xref>). The reaction proceeds through the formation of &#x3c0;-allylpalladium intermediate, which then reacts with the cyclic imine to yield the corresponding products. This approach allows for the diastereoselective synthesis of imidazolidine-fused tricyclic molecules. For type iii), Sengoden et al. reported copper-catalyzed reaction of aziridine with <italic>N</italic>-alkylanilines (<xref ref-type="bibr" rid="B12">Sengoden et al., 2017</xref>). This reaction involves the oxidation of aniline derivatives to generate an iminium intermediate <italic>in situ</italic>, which allows the efficient preparation of <italic>N-</italic>aryl-<italic>N</italic>-sulfonylimidazolidines. Despite the availability of various methods for accessing imidazolidines from aziridines, copper-catalyzed reactions of aziridines with imines or isocyanates have remained relatively underdeveloped (<xref ref-type="bibr" rid="B19">Zhu and Chiba, 2016</xref>; <xref ref-type="bibr" rid="B2">Bozorov et al., 2019</xref>; <xref ref-type="bibr" rid="B9">Pal et al., 2020</xref>; <xref ref-type="bibr" rid="B10">Pineschi, 2020</xref>; <xref ref-type="bibr" rid="B18">Zhang et al., 2022</xref>).</p>
<p>In this context, our previous study demonstrated the reaction of aziridine with diazetidine (<xref ref-type="fig" rid="F1">Figure 1C</xref>), which led to the formation of imidazolidines (<xref ref-type="bibr" rid="B3">Higuchi et al., 2023</xref>). While the scope of this reaction was broad to construct various imidazolidines, the synthetic limitation associated with diazetidine hindered its widespread use for accessing imidazolidine derivatives. During our mechanistic investigation, we disclosed that an <italic>in situ</italic> formed imine reacted with aziridine to form the corresponding imidazolidine. This discovery motivated us to explore the reaction of aziridines with substituted imines to expand the scope of this transformation. Herein, we report the copper-catalyzed synthesis of imidazolidines through the reaction of aziridines with imines (<xref ref-type="fig" rid="F1">Figure 1D</xref>). This transformation exhibits good functional group compatibility to afford the desired products efficiently. Additionally, we have successfully demonstrated that the use of isocyanates instead of imines allows accessing imidazolidinones. We have shown its application in the synthesis of hybrid molecules derived from Celecoxib and NLRP3 inflammasome inhibitor.</p>
</sec>
<sec sec-type="results|discussion" id="s2">
<title>2 Results and discussions</title>
<p>We initiated our study by investigating the ligand effect for the reaction. The treatment of aziridine <bold>1a</bold> with imine <bold>2a</bold> in the presence of 10&#xa0;mol% of CuBr and <bold>L1</bold> in toluene at 120&#xa0;&#xb0;C for 20&#xa0;h afforded the corresponding imidazolidine <bold>3a</bold> in 72% isolated yield (<xref ref-type="fig" rid="F2">Figure 2A</xref>). It is noteworthy that the ligand effect is critical where 6% of <bold>3a</bold> was obtained without the addition of <bold>L1</bold>. Furthermore, CuBr was found to be essential for the reaction, and no product was observed in the absence of both CuBr and <bold>L1</bold>. We then investigated the effect of ligands (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Although no clear correlation between ligand structure and catalytic activity was observed, 1,10-phenanthroline derivatives showed good results (<sup>1</sup>H NMR yields using various ligands <bold>L2</bold>: 74% <bold>L3</bold>: 49%, <bold>L4</bold>: 43%). Similarly, 2,2-bipyridine derivatives also promoted the reaction (<bold>L5</bold>&#x2013;<bold>L8</bold>: 14%&#x2013;72% <sup>1</sup>H NMR yields.). After the screening, we decided to use <bold>L1</bold> as the optimal ligand because it provided the highest isolated yield.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Reaction of aziridine with imine. <bold>(B)</bold> Effect of ligand. <sup>1</sup>H NMR yields were shown using 1,1,2,2-tetrachloroethane.</p>
</caption>
<graphic xlink:href="fchem-11-1272034-g002.tif"/>
</fig>
<p>The scope of the reaction was investigated (<xref ref-type="fig" rid="F3">Figure 3</xref>). Initially, we examined the substituent effect on imines. The use of electron-withdrawing <italic>p</italic>-trifluoromethylphenyl group at the R<sup>1</sup> position allowed an efficient transformation to give <bold>3b</bold> in 80% yield. Other electron-withdrawing groups, such as <italic>p</italic>-bromo- or <italic>p</italic>-chlorophenyl groups, provided the corresponding products <bold>3c</bold> and <bold>3d</bold> in 88% and 84% yields, respectively. It is noteworthy that such halogen moieties can serve as footholds for further transformation. The reactions of electron-donating <italic>p</italic>-methyl- or <italic>p</italic>-methoxyphenyl-substituted imines were relatively sluggish, however, both starting materials were completely consumed. Not only <italic>p-</italic>substituted one but also <italic>m-</italic>substituted phenylsulfonylimine reacted smoothly converted to <bold>3g</bold> in 81% yield. Despite the bulky <italic>o</italic>-bromo-, or <italic>o</italic>-nitrophenyl groups, the corresponding products <bold>3h</bold> and <bold>3i</bold> were obtained in moderate to high yields. Although the yield was not high, imine <bold>2j</bold> derived from cinnamaldehyde, was applicable to the reaction to afford <bold>3j</bold> in 34% yield. A variety of sulfonyl groups were tolerated under the reaction conditions, where methylsulfonyl (Ms) or <italic>o</italic>-nitrophenylsulfonyl (Ns)-substituted imines provided <bold>3k</bold> and <bold>3l</bold> in 84% and 67% yields without the loss of these sulfonyl groups. When electron-donating group-substituted arylsulfonylaziridines were employed, the reactions were less effective and gave <bold>3m</bold> and <bold>3n</bold> in 25% and 49% yields, respectively. Furthermore, the reaction was applicable to cyclic imine to give <bold>3o</bold> in almost quantitative yield. Unsuccessful combinations of substrates are summarized at the bottom of <xref ref-type="fig" rid="F3">Figure 3</xref>. The reactions of <italic>N</italic>-phenylimine or <italic>N</italic>-sulfoxyimine with <bold>1a</bold> failed to give the corresponding products. Although the reaction of unsubstituted aziridine <bold>1a</bold> with imine <bold>2a</bold> smoothly provided the products, the reaction of diphenylmethanimine or substituted aziridine failed. This can be attributed to steric hindrance, as the reaction of substituted aziridine proceeded smoothly with methanimine derivatives (<xref ref-type="bibr" rid="B3">Higuchi et al., 2023</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Scope of imidazolidine synthesis. <sup>a</sup> reaction time: 40&#xa0;h.</p>
</caption>
<graphic xlink:href="fchem-11-1272034-g003.tif"/>
</fig>
<p>To expand the scope of the reaction, we employed isocyanate <bold>4</bold> as the coupling partner (<xref ref-type="fig" rid="F4">Figure 4</xref>). The reaction of tosylaziridine <bold>1a</bold> with phenylisocyanate <bold>4a</bold> under the same optimized conditions afforded imidazolidinone <bold>5a</bold> in 74% yield. A variety of arylisocyanate was applicable to the reaction where electron-withdrawing <italic>p</italic>-acetyl-, <italic>p</italic>-chloro-, or electron-donating <italic>p-</italic>methoxyphenylisocyanate gave products <bold>5b</bold>&#x2013;<bold>5d</bold> in 60%&#x2013;83% yields. When tosylisocyanate was employed as the substrate, product <bold>5e</bold> was obtained in 64% yield. We then investigated the scope of substituted aziridines. Compared with the reaction with imine, the reaction with isocyanate showed a broader substrate scope of aziridines. The reaction of vinylaziridine afforded <bold>5f</bold> in 43% yield, and no isolable byproduct that reacted with the olefin was observed, leaving less than 20% of vinylaziridine remaining. Other substituents, such as methoxycarbonyl, benzyl, or biphenyl groups, were applicable to the reaction to give <bold>5g</bold>&#x2013;<bold>5i</bold> in 36%&#x2013;56% yields. Bicyclic aziridine <bold>1h</bold>, which can be prepared from cyclohexene, reacted to give <bold>5j</bold> in 22% yield. Although the yield was not high, the formal <italic>cis</italic>-diamination product can be obtained through this transformation (<xref ref-type="bibr" rid="B7">Minakata et al., 2021</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Scope of imidazolidinone synthesis.</p>
</caption>
<graphic xlink:href="fchem-11-1272034-g004.tif"/>
</fig>
<p>A proposed mechanism is shown in <xref ref-type="fig" rid="F5">Figure 5</xref>. The reaction initiates with the coordination of aziridine <bold>1</bold> to copper catalyst <bold>A</bold> to give the corresponding intermediate <bold>B</bold> (or <bold>B&#x2032;</bold>). Subsequently, imine <bold>2</bold> attacks to open the aziridine ring to give intermediate <bold>C</bold> (or <bold>C&#x2019;</bold>). Finally, a cyclization reaction takes place from <bold>C</bold> to give product <bold>3</bold>. From the result of the competitive experiment, the electron-donating group might reduce the reactivity of intermediate <bold>C</bold>, which hampers the cyclization and eventually the turnover of the catalyst. Note that another reaction mechanism can be depicted (see <xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). At this stage, we considered that the reaction with isocyanate also proceeded through a similar reaction mechanism. Because it is difficult to elucidate the full reaction mechanism, further investigation is ongoing.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Proposed mechanism.</p>
</caption>
<graphic xlink:href="fchem-11-1272034-g005.tif"/>
</fig>
<p>Finally, we applied the developed reaction to synthesize pharmaceutical hybrids (<xref ref-type="fig" rid="F6">Figure 6</xref>). Firstly, we synthesized aziridine <bold>1i</bold> from Celecoxib (<xref ref-type="bibr" rid="B8">Ozaki et al., 2021</xref>). Aziridine <bold>1i</bold> was then reacted with imine <bold>2m</bold>, derived from an NLRP3 inflammasome inhibitor, to give <bold>3p</bold> in 51% yield. Furthermore, the reaction of aziridine <bold>1i</bold> with bis-isocyanate <bold>4f</bold> afforded product <bold>5k</bold> in 95% yield. These applications clearly demonstrate the excellent functional group compatibility that allows connecting various pharmaceuticals.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Application toward the syntheses of pharmaceutical hybrids.</p>
</caption>
<graphic xlink:href="fchem-11-1272034-g006.tif"/>
</fig>
</sec>
<sec sec-type="conclusion" id="s3">
<title>3 Conclusion</title>
<p>In conclusion, we have successfully reported the copper-catalyzed reaction of aziridine with imine and isocyanate, which afforded imidazolidine and imidazolidinone respectively. These developed reactions exhibited broad functional group compatibility to access a diverse array of potential bioactive 5-membered azaheterocycles. Furthermore, to demonstrate the practical applicability of these reactions, we prepared hybrids of pharmaceutical molecules using the developed reactions. These reactions surely facilitate the syntheses of complex azaheterocycles, which will accelerate the discovery of structurally new bioactive molecules in the future.</p>
</sec>
<sec sec-type="materials|methods" id="s4">
<title>4 Materials and methods</title>
<p>For experimental procedures and compound characterization data, see the <xref ref-type="sec" rid="s10">Supplementary Materials</xref>.</p>
<sec id="s4-1">
<title>4.1 Experimental section</title>
<sec id="s4-1-1">
<title>4.1.1 Experimental procedures and characterization data</title>
<sec id="s4-1-1-1">
<title>4.1.1.1 General procedure for reaction of aziridine with imine</title>
<p>Aziridine (0.20&#xa0;mmol, 1.0&#xa0;equiv.), imine (0.30&#xa0;mmol, 1.5&#xa0;equiv.), copper bromide (3.0&#xa0;mg, 0.020&#xa0;mmol, 10&#xa0;mol%), and 2,9-dimethyl-1,10-phenanthroline (4.2&#xa0;mg, 0.020&#xa0;mmol, 10&#xa0;mol%) were added with a stirring bar to a dried Schlenk tube. The tube was filled with nitrogen. Toluene (0.5&#xa0;mL) was added to the tube and the mixture was stirred at 120&#xb0;C for 20&#xa0;h. The crude mixture was passed through a short pad of silica gel and concentrated <italic>in vacuo</italic>. Purification by chromatography on silica gel provided the desired product.</p>
</sec>
<sec id="s4-1-1-2">
<title>4.1.1.2 General procedure for reaction of aziridine with isocyanate</title>
<p>Aziridine (0.20&#xa0;mmol, 1.0&#xa0;equiv.), isocyanate (0.30&#xa0;mmol, 1.5&#xa0;equiv.), copper bromide (3.0&#xa0;mg, 0.020&#xa0;mmol, 10&#xa0;mol%), and 2,9-dimethyl-1,10-phenanthroline (4.2&#xa0;mg, 0.020&#xa0;mmol, 10&#xa0;mol%) were added with a stirring bar to a dried Schlenk tube. The tube was filled with nitrogen. Toluene (0.5&#xa0;mL) was added to the tube and the mixture was stirred at 120&#xb0;C for 20&#xa0;h. The crude mixture was passed through a short pad of silica gel and concentrated <italic>in vacuo</italic>. Purification by chromatography on silica gel provided the desired product.</p>
</sec>
</sec>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement </title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author contributions </title>
<p>KH: Writing&#x2013;review and editing. DH: Writing&#x2013;review and editing. SM: Writing&#x2013;review and editing. KM: Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec id="s7">
<title>Funding </title>
<p>The authors declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Japan Science and Technology Agency (JST) PRESTO Grant Number JPMJPR20D8 and the Kobayashi Foundation.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest </title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2023.1272034/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2023.1272034/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonopoulos</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kokkoris</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gerakari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mikros</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nitsotolis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vikeli</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Comparison of monotherapy versus combination antihypertensive therapy in elderly patients with essential hypertension</article-title>. <source>Angiology</source> <volume>59</volume>, <fpage>230</fpage>&#x2013;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1177/0003319707304580</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozorov</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aisa</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview</article-title>. <source>Bioorg. Med. Chem.</source> <volume>27</volume>, <fpage>3511</fpage>&#x2013;<lpage>3531</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2019.07.005</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higuchi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Matsubara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kadowaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Copper-catalyzed heterocyclic recombination of aziridine and diazetidine for the synthesis of imidazolidine</article-title>. <source>Chem. Eur. J.</source> <volume>29</volume>, <fpage>e202301071</fpage>. <pub-id pub-id-type="doi">10.1002/chem.202301071</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Oxidative dehydrogenative [2 &#x2b; 3]-cyclization of Glycine esters with aziridines leading to imidazolidines</article-title>. <source>Org. Lett.</source> <volume>20</volume>, <fpage>92</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.7b03448</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>T.-Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.-H.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.-J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Chirality transfer in rhodium(I)-Catalyzed [3 &#x2b; 2]-cycloaddition of vinyl aziridines and oxime ethers: Atom-economical synthesis of chiral imidazolidines</article-title>. <source>Org. Lett.</source> <volume>20</volume>, <fpage>3587</fpage>&#x2013;<lpage>3590</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.8b01378</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Metal-free [2 &#x2b; 1 &#x2b; 2]-cycloaddition of tosylhydrazones with hexahydro-1,3,5-triazines to form imidazolidines</article-title>. <source>Org. Lett.</source> <volume>19</volume>, <fpage>1858</fpage>&#x2013;<lpage>1861</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.7b00600</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minakata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miwa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hirayama</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Okumura</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Diastereodivergent intermolecular 1,2-diamination of unactivated alkenes enabled by iodine catalysis</article-title>. <source>J. Am. Chem. Soc.</source> <volume>143</volume>, <fpage>4112</fpage>&#x2013;<lpage>4118</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.1c00228</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yorimitsu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>G. J. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Primary sulfonamide functionalization via sulfonyl pyrroles: Seeing the N-ts bond in a different light</article-title>. <source>Chem. Eur. J.</source> <volume>27</volume>, <fpage>15387</fpage>&#x2013;<lpage>15391</lpage>. <pub-id pub-id-type="doi">10.1002/chem.202102748</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lahiri</surname>
<given-names>G. K.</given-names>
</name>
<name>
<surname>Maiti</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Copper in efficient synthesis of aromatic heterocycles with single heteroatom</article-title>. <source>Eur. J. Org. Chem.</source> <volume>2020</volume>, <fpage>6859</fpage>&#x2013;<lpage>6869</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.202000688</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pineschi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The binomial copper-catalysis and asymmetric ring opening of strained heterocycles: Past and future challenges</article-title>. <source>Eur. J. Org. Chem.</source> <volume>2020</volume>, <fpage>2643</fpage>&#x2013;<lpage>2649</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201901853</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pradhan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shahi</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ghorai</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Stereoselective synthesis of hexahydroimidazo[1,2-<italic>a</italic>]quinolines via S<sub>N</sub>2-type ring-opening hydroarylation&#x2013;hydroamination cascade cyclization of activated aziridines with <italic>N</italic>-propargylanilines</article-title>. <source>Org. Lett.</source> <volume>22</volume>, <fpage>7903</fpage>&#x2013;<lpage>7908</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.0c02801</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sengoden</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhowmick</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Punniyamurthy</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Stereospecific copper-catalyzed domino ring opening and sp3 C&#x2212;H functionalization of activated aziridines with N-alkylanilines</article-title>. <source>Org. Lett.</source> <volume>19</volume>, <fpage>158</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.6b03458</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis of diversely substituted imidazolidines <italic>via</italic> [3&#x2b;2] cycloaddition of 1,3,5&#x2010;triazinanes with donor&#x2010;acceptor aziridines and their anti&#x2010;tumor activity</article-title>. <source>Adv. Synth. Catal.</source> <volume>363</volume>, <fpage>2619</fpage>&#x2013;<lpage>2624</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.202001569</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Doershuk</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Goldmann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gore</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hilman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>Comparison of a &#x3b2;-lactam alone versus &#x3b2;-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis</article-title>. <source>J. Pediatr.</source> <volume>134</volume>, <fpage>413</fpage>&#x2013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3476(99)70197-6</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spielmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>van der Lee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Figueriedo</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Campagne</surname>
<given-names>J.-M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Diastereoselective palladium-catalyzed (3 &#x2b; 2)-cycloadditions from cyclic imines and vinyl aziridines</article-title>. <source>Org. Lett.</source> <volume>20</volume>, <fpage>1444</fpage>&#x2013;<lpage>1447</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.8b00228</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Access to imidazolidines via 1,3-dipolar cycloadditions of 1,3,5-triazinanes with aziridines</article-title>. <source>J. Org. Chem.</source> <volume>84</volume>, <fpage>11161</fpage>&#x2013;<lpage>11169</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.9b01959</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Y(OTf)<sub>3</sub>-Catalyzed diastereoselective [3&#x2b;2] cycloaddition of N-tosylaziridines and imines; efficient synthesis of multisubstituted imidazolidines</article-title>. <source>Synthesis</source> <volume>44</volume>, <fpage>2147</fpage>&#x2013;<lpage>2154</lpage>. <pub-id pub-id-type="doi">10.1055/s-0031-1290816</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Copper-catalyzed radical relay in C(sp<sup>3</sup>)&#x2013;H functionalization</article-title>. <source>Chem. Soc. Rev.</source> <volume>51</volume>, <fpage>1640</fpage>&#x2013;<lpage>1658</lpage>. <pub-id pub-id-type="doi">10.1039/d1cs00727k</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chiba</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Copper-catalyzed oxidative carbon&#x2013;heteroatom bond formation: A recent update</article-title>. <source>Chem. Soc. Rev.</source> <volume>45</volume>, <fpage>4504</fpage>&#x2013;<lpage>4523</lpage>. <pub-id pub-id-type="doi">10.1039/c5cs00882d</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>